SLC15A1: A Potential Drug Target Or Biomarker (G6564)

Target Name: SLC15A1

NCBI ID: G6564

SLC15A1

SLC15A1: A Potential Drug Target Or Biomarker

SLC15A1 is a protein that belongs to the SLC family, which is known for its role in transporting various molecules across cell membranes. SLC15A1 is a member of the oligopeptide transporter family 15, and its function is to transport oligopeptides across the cell membrane. This protein is expressed in many different tissues and cells in the body, and it is also an potential drug target or biomarker.

SLC15A1 is involved in the transport of a wide variety of oligopeptides, including proteins, nucleic acids, and other large molecules. This protein is expressed in many different tissues and cells in the body, including the brain, muscle, heart, and liver. It is also found in various bodily fluids, such as blood, plasma, and urine.

SLC15A1 is a transmembrane protein, which means that it spans the cell membrane and is involved in the transport of molecules across it. This protein is made up of 15 amino acids, and its primary function is to transport oligopeptides across the cell membrane.

SLC15A1 is involved in many different processes in the body. For example, it is involved in the regulation of protein synthesis and degradation, as well as the transport of nutrients and other molecules across cell membranes. It is also involved in the regulation of cellular signaling pathways, and it is a potential drug target or biomarker for a variety of diseases.

SLC15A1 is a potential drug target because of its involvement in the regulation of cellular signaling pathways. Many diseases, including cancer, are caused by the disruption of normal cellular signaling pathways. SLC15A1 is involved in the regulation of several signaling pathways, including the TGF-β pathway and the Wnt pathway. Disruptions in these pathways have been linked to a wide range of diseases, including cancer.

SLC15A1 is also a potential biomarker for several diseases, including cancer. The expression of SLC15A1 has been detected in a variety of cancer tissues, and its levels are often elevated in these tissues compared to non-cancerous cells. This suggests that SLC15A1 may be a useful biomarker for cancer diagnosis and treatment.

In conclusion, SLC15A1 is a protein that is expressed in many different tissues and cells in the body and is involved in the transport of oligopeptides across the cell membrane. It is also a potential drug target or biomarker for a variety of diseases, including cancer. Further research is needed to fully understand the role of SLC15A1 in the regulation of cellular signaling pathways and its potential as a drug or biomarker.

Protein Name: Solute Carrier Family 15 Member 1

Functions: Electrogenic proton-coupled amino-acid transporter that transports oligopeptides of 2 to 4 amino acids with a preference for dipeptides. Transports neutral and monovalently charged peptides with a proton to peptide stoichiometry of 1:1 or 2:1 (PubMed:7896779, PubMed:9835627, PubMed:8914574, PubMed:15521010, PubMed:18367661, PubMed:19685173) (By similarity). Primarily responsible for the absorption of dietary di- and tripeptides from the small intestinal lumen (By similarity). Mediates transepithelial transport of muramyl and N-formylated bacterial dipeptides contributing to recognition of pathogenic bacteria by the mucosal immune system (PubMed:9835627, PubMed:15521010)

The "SLC15A1 Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about SLC15A1 comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets